Voclosporin is an immunosuppressive agent used in the treatment of lupus nephritis, a serious kidney complication of systemic lupus erythematosus. It is a calcineurin inhibitor, similar to cyclosporine, but with improved potency and safety profile. By suppressing T-cell activation, it reduces immune-mediated damage to the kidneys. Voclosporin was approved for use in the U.S. in 2021.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Voclosporin and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Voclosporin impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Voclosporin-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
